Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Nash

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
The Journal of Rheumatology|August 1, 2023
Proceedings of the GRAPPA 2022 Executive RetreatBeverly Cheok Kuan Ng, Deepak Jadon, Adewale Adebajo, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|March 27, 2026
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS StudyMurat Torgutalp, Raquel Almodovar, Valderilio F Azevedo, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
The Journal of Rheumatology|August 1, 2023
Proceedings of the GRAPPA 2022 Executive RetreatBeverly Cheok Kuan Ng, Deepak Jadon, Adewale Adebajo, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|March 27, 2026
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS StudyMurat Torgutalp, Raquel Almodovar, Valderilio F Azevedo, et al.
Pageof 20